Practice
Featured experience
Global Eggs $1.1 billion acquisition of Hillandale Farms
We advised the buyer in connection with this transaction and the related acquisition financing
Strive Asset Management combination with Asset Entities
We are advising Strive on the transaction
TPG and Corpay $2.2 billion acquisition of AvidXchange Holdings
We are advising TPG on the transaction
Airbus acquisition of certain assets and sites from Spirit AeroSystems
We are advising Airbus on the transaction
Davis Polk Advises FormFactor on Its Acquisition of Cascade Microtech
Davis Polk is advising FormFactor, Inc. in connection with its acquisition of Cascade Microtech, Inc. for a total equity…
Abbott Acquires Alere
Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by…
Stryker Acquires Sage Products from Madison Dearborn Partners
Davis Polk is advising JP Morgan as financial adviser to Stryker Corporation in connection with its $2.775 billion…
Davis Polk Advises Lightyear Capital and Clarion Partners on the Sale of Clarion Partners to Legg Mason
Davis Polk is advising Lightyear Capital LLC and Clarion Partners Holdings LLC on the sale of Clarion Partners to Legg Mason…
ChipMOS Taiwan merger with ChipMOS Bermuda
Davis Polk is advising ChipMOS TECHNOLOGIES INC. (“ChipMOS Taiwan”) in connection with its proposed merger with its parent…
Biotie acquisition by Acorda
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…
Davis Polk Advises I Squared Capital on Its Acquisition of Lincoln Clean Energy
Davis Polk is advising I Squared Capital in connection with its acquisition of Lincoln Clean Energy through its ISQ Global…
Davis Polk Advises Affymetrix on Its Sale to Thermo Fisher
Davis Polk is advising Affymetrix, Inc. in connection with its sale to Thermo Fisher Scientific Inc. for a total equity…
Davis Polk Advises Charles River Laboratories on Its Acquisition of WIL Research
Davis Polk is advising Charles River Laboratories International, Inc. on its acquisition of WIL Research for approximately …
Davis Polk Advises China Cinda on a Strategic Investment by Sino Biopharmaceutical
Davis Polk is advising China Cinda Asset Management Co., Ltd. (“China Cinda”) in connection with a proposed strategic…